Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 2
1955 1
1956 1
1957 1
1958 2
1959 1
1960 1
1961 1
1962 1
1963 2
1965 6
1966 1
1967 5
1968 5
1970 2
1971 6
1972 1
1973 5
1974 5
1975 3
1976 7
1977 5
1978 10
1979 12
1980 9
1981 8
1982 13
1983 11
1984 10
1985 25
1986 14
1987 22
1988 24
1989 26
1990 29
1991 28
1992 45
1993 33
1994 30
1995 31
1996 36
1997 54
1998 71
1999 57
2000 62
2001 65
2002 79
2003 87
2004 93
2005 85
2006 108
2007 95
2008 83
2009 79
2010 95
2011 80
2012 90
2013 92
2014 90
2015 80
2016 96
2017 107
2018 106
2019 71
2020 100
2021 114
2022 99
2023 13
Text availability
Article attribute
Article type
Publication date

Search Results

2,530 results
Results by year
Filters applied: . Clear all
Page 1
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation.
Marty FM, Ljungman P, Chemaly RF, Maertens J, Dadwal SS, Duarte RF, Haider S, Ullmann AJ, Katayama Y, Brown J, Mullane KM, Boeckh M, Blumberg EA, Einsele H, Snydman DR, Kanda Y, DiNubile MJ, Teal VL, Wan H, Murata Y, Kartsonis NA, Leavitt RY, Badshah C. Marty FM, et al. Among authors: murata y. N Engl J Med. 2017 Dec 21;377(25):2433-2444. doi: 10.1056/NEJMoa1706640. Epub 2017 Dec 6. N Engl J Med. 2017. PMID: 29211658 Free article. Clinical Trial.
A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation.
Ljungman P, Schmitt M, Marty FM, Maertens J, Chemaly RF, Kartsonis NA, Butterton JR, Wan H, Teal VL, Sarratt K, Murata Y, Leavitt RY, Badshah C. Ljungman P, et al. Among authors: murata y. Clin Infect Dis. 2020 Apr 10;70(8):1525-1533. doi: 10.1093/cid/ciz490. Clin Infect Dis. 2020. PMID: 31179485 Free PMC article. Clinical Trial.
Double-Holed Fullerenes.
Hashikawa Y, Fushino T, Murata Y. Hashikawa Y, et al. Among authors: murata y. J Am Chem Soc. 2020 Dec 9;142(49):20572-20576. doi: 10.1021/jacs.0c10676. Epub 2020 Nov 9. J Am Chem Soc. 2020. PMID: 33164533
Cervical Pott's disease.
Murata Y, Tomoda Y. Murata Y, et al. IDCases. 2021 Oct 5;26:e01303. doi: 10.1016/j.idcr.2021.e01303. eCollection 2021. IDCases. 2021. PMID: 34667718 Free PMC article. No abstract available.
Cage-Expansion of Fullerenes.
Zhang S, Hashikawa Y, Murata Y. Zhang S, et al. Among authors: murata y. J Am Chem Soc. 2021 Aug 18;143(32):12450-12454. doi: 10.1021/jacs.1c05778. Epub 2021 Jul 29. J Am Chem Soc. 2021. PMID: 34324333
2,530 results